{
    "ticker": "SWKHL",
    "name": "SWK Holdings Corporation",
    "description": "SWK Holdings Corporation is a specialty finance company focused on providing innovative financing solutions to the life sciences sector, particularly in biotechnology and pharmaceutical industries. Founded in 2012, SWK offers flexible capital solutions through its unique financing structures, including secured loans, royalties, and equity investments. The company's mission is to bridge the financing gap in the life sciences industry, enabling companies to advance their research and development efforts, while mitigating the risks associated with traditional financing methods. SWK Holdings is particularly known for its creative approaches to funding, which allows it to support early-stage companies that may not have access to conventional lending sources. By aligning its interests with those of its portfolio companies, SWK aims to foster growth and enhance the value of its investments, ultimately contributing to the advancement of medical innovations. The company has established a strong reputation in the industry, leveraging its experienced team and extensive network to identify and partner with promising life sciences firms. With a commitment to responsible investment and a deep understanding of the healthcare landscape, SWK Holdings continues to play a pivotal role in driving innovation and improving patient outcomes.",
    "industry": [
        "Finance",
        "Life Sciences"
    ],
    "headquarters": "Dallas, Texas, USA",
    "founded": "2012",
    "website": "https://www.swkholding.com",
    "ceo": "W. Scott Kauffman",
    "social_media": {
        "twitter": "https://twitter.com/SWKHoldings",
        "linkedin": "https://www.linkedin.com/company/swk-holdings-corporation/"
    },
    "investor_relations": "https://www.swkholding.com/investor-relations",
    "key_executives": [
        {
            "name": "W. Scott Kauffman",
            "position": "CEO"
        },
        {
            "name": "Michael J. Gorman",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Financing Solutions",
            "products": [
                "Secured Loans",
                "Royalty Financing",
                "Equity Investments"
            ]
        }
    ],
    "seo": {
        "meta_title": "SWK Holdings Corporation | Specialty Finance for Life Sciences",
        "meta_description": "Explore SWK Holdings Corporation, a leader in providing innovative financing solutions tailored for the life sciences industry, supporting biotech and pharmaceutical advancements.",
        "keywords": [
            "SWK Holdings",
            "Specialty Finance",
            "Life Sciences",
            "Biotechnology Financing",
            "Pharmaceutical Investments",
            "Royalty Financing"
        ]
    },
    "faq": [
        {
            "question": "What does SWK Holdings specialize in?",
            "answer": "SWK Holdings specializes in providing innovative financing solutions for the life sciences sector, including biotechnology and pharmaceuticals."
        },
        {
            "question": "Who is the CEO of SWK Holdings?",
            "answer": "W. Scott Kauffman is the CEO of SWK Holdings Corporation."
        },
        {
            "question": "Where is SWK Holdings headquartered?",
            "answer": "SWK Holdings is headquartered in Dallas, Texas, USA."
        },
        {
            "question": "What types of financing does SWK Holdings offer?",
            "answer": "SWK Holdings offers secured loans, royalty financing, and equity investments."
        },
        {
            "question": "When was SWK Holdings founded?",
            "answer": "SWK Holdings was founded in 2012."
        }
    ],
    "competitors": [
        "HCM",
        "THLD",
        "CLRB"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}